top of page
Espacio de trabajo moderna

Strategic Services

The future of healthcare is here

At MEDSIR, we position you to lead the change. Our strategic model unlocks the full power of your unique assets, driving growth and ensuring your long-term success in an increasingly competitive market.

DISRUPTING ONCOLOGY RESEARCH

We're looking for you

Redefining the way clinical trials are designed, executed, and optimized.

 

With over a decade of experience and an international presence, we accelerate oncology drug development for biotech, pharma, and healthcare companies by delivering results that matter.

SERVICES DESIGNED TO WIN

We're looking for you

We partner with your company to deliver tailor-made solutions that accelerate your oncology pipeline. Our 360º Clinical Development Strategy ensures you have the full support you need, from study design to patient recruitment and final publication.

Icon_Results bg.png

Clinical Development Support Services

Planning is 80 %
of the success

End-to-End Study Design & Optimization​​.

At MEDSIR, we understand the challenges while planning the clinical development as multiple factors need to be taken into consideration.

We have developed a tailored solution to support you and ensure the best possible outcomes.

Get the most out of your clinical trials with top-tier protocol optimization. Pinpoint the right patient populations with precision-based strategies.

 

Icon_Study Phase bg.png

Patient Recruitment Strategy

Tailored strategic services designed to accelerate your growth

Adhering to patient recruitment timelines is vital for the success of a clinical trial, as delays can significantly impact study outcomes, costs, and the overall development timeline.

Icon_Study Details bg.png

Operational Strategy

A High-Impact Strategic Operations

Defining strategic operational activities is essential for maximizing efficiency and effectiveness in clinical trial execution. This leads to streamlined processes, shorter timelines, and higher-quality results.

Our experienced operations team is ready to support you at every stage. We offer process agility, fast recruitment, and a precise, high-impact approach to ensure the success of your trials.

 

Icon_Impression_bg.png

Research Training

Research added value for better treatments

Promoting and enriching impactful research by understanding the crucial value of the medical community in the design and management of clinical trials.

Research strategies for the successful clinical development of potential new molecules should be founded on scientifically meaningful approaches and executed with efficiency.​​

 

fondo1~mv2.webp

"

YOUR SCIENCE DESERVES
MORE THAN JUST RESEARCH.

We're looking for you

PARTNER WITH US AND LEAD THE FUTURE

mature-businessman-with-smartphone-in-the-office-2023-11-27-04-56-05-utc 1.webp

BOOK A MEETING

home_fondo_you_barra.jpg

Use this contact form for any inquiries regarding MEDSIR Strategic Services and our solutions.

We will do our best to respond as soon as possible.

Service interested

THE MEDSIR ADVANTAGE

home_fondo_tolife_barra.jpg

When you partner with us, you’re not just getting a service provider. You’re gaining a strategic partner committed to delivering real results

We proudly collaborate across
19+ countries 
providing strategic support to drive continued growth.

Picture1.png
Why industry leaders choose us:
Speed

We move from idea to clinical trial signature in as little as 6 months.

Flexibility

We adapt to your unique needs with custom strategies.

Impact

We don't just participate in oncology trials – we lead them.

SOME OF OUR CLINICAL TRIALS

We're looking for you

PHERGAIN

BREAST

Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: A FDG-PET response-adapted strategy

ADELA

BREAST

Elacestrant + Everolimus in Patients ER+/​HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/​6i.

TUXEDO-3

BRAIN METS

HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease

LUPER

LUNG

Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.

MEET OUR EXPERTS

We're looking for you
Rui Rui .jpeg

Rui Rui Zhang Xiang

Business Development Director

Boston

danilo belloso.jpeg

Danilo Belloso

Business Development Director

New Jersey

miquel quintana.jpeg

Miquel Quintana

Clinical Strategic Consulting Services

Barcelona

We're looking for you

INSIGHTS

SOME CLINICAL EXPERTS COLLABORATING
WITH MEDSIR

We're looking for you

JAVIER

CORTÉS

Medical Oncologist 
MD, PhD

PETER SCHMID

Medical Oncologist MD, PhD

ANTONIO

LLOMBART

Medical Oncologist 
MD, PhD

JORDI 

REMON

Medical Oncologist 
MD, PhD

MARTA 
VAZ-BAPTISTA

Medical Oncologist 
MD

JOSEPH GLIGOROV

Medical Oncologist 
MD, PhD

FREDERIK MARMÉ

Gynecologist 
MD

NOEMÍ REGUART

Medical Oncologist 
MD, PhD

MARINA GARASSINO

Medical Oncologist 
MD, PhD

PETER

KAUFMAN

Medical Oncologist 
MD

JOAN CARLES

Medical Oncologist 
MD, PhD

JOSEP MARIA

PIULATS

Medical

Oncologist 
MD, PhD

NIKI KARACHALIOU

Medical Oncologist 
MD, PhD

JOSÉ
PÉREZ

Medical Oncologist 
MD, PhD

ANTONIO

CALLES

Medical Oncologist MD, PhD

JAVIER GARDE

Medical Oncologist 
MD

bottom of page